Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Diencephalic Size Is Restricted by a Novel Interplay Between GCN5 Acetyltransferase Activity and Retinoic Acid Signaling.

The Journal of neuroscience : the official journal of the Society for Neuroscience | 2017

Diencephalic defects underlie an array of neurological diseases. Previous studies have suggested that retinoic acid (RA) signaling is involved in diencephalic development at late stages of embryonic development, but its roles and mechanisms of action during early neural development are still unclear. Here we demonstrate that mice lacking enzymatic activity of the acetyltransferase GCN5 ((Gcn5hat/hat )), which were previously characterized with respect to their exencephalic phenotype, exhibit significant diencephalic expansion, decreased diencephalic RA signaling, and increased diencephalic WNT and SHH signaling. Using a variety of molecular biology techniques in both cultured neuroepithelial cells treated with a GCN5 inhibitor and forebrain tissue from (Gcn5hat/hat ) embryos, we demonstrate that GCN5, RARα/γ, and the poorly characterized protein TACC1 form a complex in the nucleus that binds specific retinoic acid response elements in the absence of RA. Furthermore, RA triggers GCN5-mediated acetylation of TACC1, which results in dissociation of TACC1 from retinoic acid response elements and leads to transcriptional activation of RA target genes. Intriguingly, RA signaling defects caused by in vitro inhibition of GCN5 can be rescued through RA-dependent mechanisms that require RARβ. Last, we demonstrate that the diencephalic expansion and transcriptional defects seen in (Gcn5hat/hat ) mutants can be rescued with gestational RA supplementation, supporting a direct link between GCN5, TACC1, and RA signaling in the developing diencephalon. Together, our studies identify a novel, nonhistone substrate for GCN5 whose modification regulates a previously undescribed, tissue-specific mechanism of RA signaling that is required to restrict diencephalic size during early forebrain development.SIGNIFICANCE STATEMENT Changes in diencephalic size and shape, as well as SNPs associated with retinoic acid (RA) signaling-associated genes, have been linked to neuropsychiatric disorders. However, the mechanisms that regulate diencephalic morphogenesis and the involvement of RA signaling in this process are poorly understood. Here we demonstrate a novel role of the acetyltransferase GCN5 in a previously undescribed mechanism of RA signaling in the developing forebrain that is required to maintain the appropriate size of the diencephalon. Together, our experiments identify a novel nonhistone substrate of GCN5, highlight an essential role for both GCN5 and RA signaling in early diencephalic development, and elucidate a novel molecular regulatory mechanism for RA signaling that is specific to the developing forebrain.

Pubmed ID: 28154153 RIS Download

Research resources used in this publication

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: F31 NS087692

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


IRDye 800CW Goat anti-Rabbit IgG (antibody)

RRID:AB_621843

This polyclonal secondary targets IgG

View all literature mentions

PAX7 (antibody)

RRID:AB_2299243

This monoclonal targets PAX7

View all literature mentions

MASH1 (antibody)

RRID:AB_396479

This monoclonal targets Recombinant full length rat MASH1 protein

View all literature mentions

p21 (antibody)

RRID:AB_396415

This monoclonal targets p21

View all literature mentions

RARalpha (C-20) (antibody)

RRID:AB_2177750

This monoclonal targets Raised against peptide mapping to the carboxy terminus

View all literature mentions

Normal Mouse IgG (antibody)

RRID:AB_145840

This polyclonal secondary targets not applicable

View all literature mentions

RpII215-dmelanogaster (antibody)

RRID:AB_309852

This monoclonal targets RpII215

View all literature mentions

Acetylated-Lysine Antibody (antibody)

RRID:AB_331805

This polyclonal targets Acetylated-Lysine

View all literature mentions

LEF1 (C12A5) Rabbit mAb (antibody)

RRID:AB_823558

This monoclonal targets LEF1 (C12A5) Rabbit mAb

View all literature mentions

RARalpha (L-15) (antibody)

RRID:AB_2177747

This polyclonal targets RARA

View all literature mentions

GCN5L2 (C26A10) Rabbit mAb (antibody)

RRID:AB_2128281

This monoclonal targets GCN5L2

View all literature mentions

Anti-TACC1, N-Terminal antibody produced in rabbit (antibody)

RRID:AB_10747337

This polyclonal targets TACC1 N-Terminal antibody produced in rabbit

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

NE-4C (cell line)

RRID:CVCL_B063

Cell line NE-4C is a Spontaneously immortalized cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

PAX7 (antibody)

RRID:AB_2299243

This monoclonal targets PAX7

View all literature mentions

MASH1 (antibody)

RRID:AB_396479

This monoclonal targets Recombinant full length rat MASH1 protein

View all literature mentions

p21 (antibody)

RRID:AB_396415

This monoclonal targets p21

View all literature mentions

LEF1 (C12A5) Rabbit mAb (antibody)

RRID:AB_823558

This monoclonal targets LEF1 (C12A5) Rabbit mAb

View all literature mentions

RARalpha (L-15) (antibody)

RRID:AB_2177747

This polyclonal targets RARA

View all literature mentions

GCN5L2 (C26A10) Rabbit mAb (antibody)

RRID:AB_2128281

This monoclonal targets GCN5L2

View all literature mentions

RARalpha (C-20) (antibody)

RRID:AB_2177750

This monoclonal targets Raised against peptide mapping to the carboxy terminus

View all literature mentions

RpII215-dmelanogaster (antibody)

RRID:AB_309852

This monoclonal targets RpII215

View all literature mentions

Anti-TACC1, N-Terminal antibody produced in rabbit (antibody)

RRID:AB_10747337

This polyclonal targets TACC1 N-Terminal antibody produced in rabbit

View all literature mentions

Normal Mouse IgG (antibody)

RRID:AB_145840

This polyclonal secondary targets not applicable

View all literature mentions

Acetylated-Lysine Antibody (antibody)

RRID:AB_331805

This polyclonal targets Acetylated-Lysine

View all literature mentions

IRDye 800CW Goat anti-Rabbit IgG (antibody)

RRID:AB_621843

This polyclonal secondary targets IgG

View all literature mentions